✦ LIBER ✦

PGN 1091, a novel 5-HT2B receptor antagnist for the treatment of irritable bowel syndrome

✍ Scribed by Borman, Richard; Oxford, Alec; Denny, Sarah; Sykes, Andrew; Samra, Satinder; Woodrooffe, Amanda; Eagle, mark; Coleman, Robert; Clark, Ken

Book ID: 122896964
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 258 KB
Volume: 124
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(03)82881-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety Profile of Tegaserod, a 5-HT4Rece

Safety Profile of Tegaserod, a 5-HT4Receptor Agonist, for the Treatment of Irritable Bowel Syndrome

✍ Dr William L. Hasler, Philip Schoenfeld 📂 Article 📅 2004 🏛 Springer International Publishing AG 🌐 English ⚖ 127 KB

5-HT 3 Receptor Partial Agonist Modulati

5-HT 3 Receptor Partial Agonist Modulation, a Novel Approach to the Treatment of Diarrhea Predominant Irritable Bowel Syndrome (IBS-D)

✍ Manning, David ;Wierschke, Jonathan D. ;Barnes, Nicholas M. ;Moore, Nicholas 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 133 KB

Alosetron, a 5HT3-receptor antagonist, i

Alosetron, a 5HT3-receptor antagonist, is effective in the treatment of female irritable bowel syndrome patients

✍ Northcutt, AR; Camilleri, M; Mayer, EA; Drossman, DA; Dukes, GE; Ehsanullah, RSB 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 177 KB

ChemInform Abstract: Design and Synthesi

ChemInform Abstract: Design and Synthesis of Piperazinylpyridine Derivatives as Novel 5-HT1A Agonists/5-HT3 Antagonists for the Treatment of Irritable Bowel Syndrome (IBS).

✍ Akira Asagarasu; Teruaki Matsui; Hiroyuki Hayashi; Satoru Tamaoki; Yukinao Yamau 📂 Article 📅 2009 🏛 John Wiley and Sons ⚖ 15 KB 👁 2 views

Novel serotonin type 3 receptor partial

Novel serotonin type 3 receptor partial agonists for the potential treatment of irritable bowel syndrome

✍ David D. Manning; Christopher L. Cioffi; Alexander Usyatinsky; Kevin Fitzpatrick 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 474 KB

Serotonin type 3 (5-HT(3)) receptor partial agonists are being targeted as potential new drugs for the treatment of irritable bowel syndrome (IBS). Two new chemical series bearing indazole and indole cores have exhibited nanomolar binding affinity for the h5-HT(3)A receptor. A range of partial agoni

Su1988 Novel Therapeutic Approaches for

Su1988 Novel Therapeutic Approaches for Treatment of Irritable Bowel Syndrome Using the Multi-Herbal Drug STW 5

✍ Nieber, Karen; Voss, Ulrike; Hoser, Stefanie; Michael, Sebastian; Abdel-Aziz, He 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 114 KB